OBR Daily Commentary

forumImage

Precision Oncology Drug Yields Impressive Results, Showing Power Of Cancer Genomics

(Forbes) June 9, 2017 - One of the most remarkable papers from this year’s big cancer meeting drew attention to an experimental drug called larotrectinib.

Read Article arrow

Winston Wong, PharmD (Posted: June 12, 2017)

quotesVery positive for the genomic profiling movement. It goes along with the approval of Keytruda for cancers based upon a genomic result. This will be a challenge for for payers.quotes

Add Comment 1 Comment
forumImage

AMA Will Vote On Requiring Drug Makers To Disclose Prices In Consumer Ads

(STAT Plus) June 6, 2017 - In its latest bid to restrain pharmaceutical advertising, the American Medical Association will vote on a resolution to demand that drug makers disclose pricing in ads that are aimed at consumers.

Read Article arrow

Winston Wong, PharmD (Posted: June 12, 2017)

quotesThe last time I looked up banning DTC ads, the US was only one of two countries that actually allowed advertisement on medications. We have plenty of other things that are banned, so why not DTC ads. think of the billions of dollars that goes into DTC ad, which could either be put back into the system, or used to low prices.quotes

Add Comment 1 Comment
forumImage

UnitedHealth and Merck Strike A Deal To Explore Linking Payments To Drug Performance

(CNBC) May 25, 2017 - UnitedHealth Group's Optum unit has signed a multiyear agreement with Merck to develop a better way to reimburse drugmakers based on how well their drugs improve a patient's health.

Read Article arrow

Winston Wong, PharmD (Posted: June 08, 2017)

quotesWhile outcomes based contracting resented to the issue of recovering wasted cost for ineffective therapies, does it really address the high cost to begin with, and addressing the value of the therapy. So the regimen helps the patient achieve therapeutic endpoints, but that does not necessarily translate to a cost effective treatment option. A high cost is still a high cost, even if you hit your endpoints.quotes

Add Comment 1 Comment

Meet the Editorial Board

Community Oncology
member photo
Dean Gesme, MD

FACP FACPE FASCO President, Minnesota Oncology...

Breast Cancer
member photo
Debu Tripathy, MD

Professor and Chair, Department of Breast Medical Oncol...

Lung Cancer
member photo
H. Jack West, MD

Medical Director, Thoracic Oncology Program, Swedish Ca...

Gastrointestinal Cancers
member photo
Howard S. Hochster, MD

Associate Cancer Center Director, Yale Cancer Center P...

Community Oncology
member photo
Jeff Patton, M.D.

CEO Tennessee Oncology...

Precision Medicine Section Editor
member photo
Jennifer Levin Carter, MD, MPH

Chief Medical Officer and Founder, N-of-One...

Financial Sector
member photo
Michael G. King Jr.

Managing Director and Senior Biotechnology Analyst...

Gastrointestinal Cancers
member photo
Richard Goldberg, MD

Director WVU Cancer Institute Director of Cancer Signa...

Editor-In-Chief
member photo
Robert A. Figlin, MD., FACP

Professor and Director, Division of Hematology Oncology...

Health Policy
member photo
Ted Okon

Executive Director Community Oncology Alliance...

Community Oncology
member photo
Thomas Marsland, MD

Vice President Integrated Community Oncology Network ...

Community Oncology
member photo
William Harwin MD

Florida Cancer Specialists President and Managing Part...

Health Policy
member photo
William McGivney, PhD

National Health Policy Expert...

Payer
member photo
Winston Wong, PharmD

President, W-Squared Group...